LINC00973 and colorectal carcinoma: More recently, researchers further indicated the potential roles and the underlying mechanism of some lncRNAs in the field of acquired resistance to cetuximab 8-10, including lncRNA MIR100HG, POU5F1P4 and LINC00973, which may lead to the identification of novel therapeutic targets for treating late-stage CRC.